Fox Business - The Power to Prosper
Search Site

Hospira

Ralph Lauren shares under pressure with weak forecast

FBN’s Nicole Petallides on the highlights from the day in the markets.

Read More

  1. Hospira CEO: We’ll help the Affordable Care Act save money

    Hospira CEO Mike Ball discusses the company’s growth, new devices, future outlook and the impact of ObamaCare on the company.

  2. U.S. probes possible medical devices hacks

    FBN’s Liz MacDonald on the U.S. Department of Homeland Security’s investigation into about two-dozen cases of suspected cybersecurity flaws in medical devices and hospital equipment.

  3. Mid-cap stock picks

    Wells Capital Management portfolio manager Bryant Vancronkhite gives tips for investing in mid cap names.

  4. U.S. court ruling favors Cubist in patent case versus Hospira

    A federal court on Monday ruled in favor of Cubist Pharmaceuticals Inc on the interpretation of patent language in a case involving a generic challenge to its lead d...

  5. Health Care Sector Wrap

    The Health Care sector (XLV) showed little movement on a trading day that saw S&P 500 fall 0.7%.Repligen Corporation (NASDAQ:RGEN) was a significant gainer in the se...

  6. Hospira Shares Jump On Earnings News

    Shares of Hospira Inc. climbed more than 5% Wednesday morning after the maker of injectable drugs reported second-quarter earnings that beat analyst estimates. The c...

  7. Hospira Recalls Cancer Drugs Due to Glass Particles

    Hospira Inc said it has issued a nationwide recall of four of its injectable cancer drugs because of particles embedded in the glass at the neck of the vial.The drug...

  8. Royal Gold, Comcast Included in Stocks Up on High Volume Monday

    There are a few stocks that are up on high volume today:Royal Gold (NASDAQ:RGLD) was up on high volume today, after trading at a volume of 8.5 million, or 8.4 times ...

  9. WSJ BLOG/Health: FDA Approves New Suppliers for Scarce Cancer Drugs

    (This story has been posted on The Wall Street Journal Online's Health Blog at http://blogs.wsj.com/health.)New supplies of two currently hard-to-find cancer drugs a...

  10. Hospira Shares Jump On Strong Earnings Report

    Hospira Inc. shares rose as much as 9% at the open Tuesday, making it the biggest percentage gainer in the S&P 500 Index. The move followed the release of the specia...

  11. Durect Plunges 33% On Failed Drug Study

    Shares of Durect Corp. plunged 33% to 79 cents on Friday, the day after it reported that a Phase III clinical trial failed to show its painkiller Posidur was effecti...

  12. Hospira Names John Staley Non-executive Chairman

    Hospira Inc. said late Wednesday it named John Staley its new non-executive chairman with the retirement of current chairman Christopher Begley. Staley, 70, will suc...

  1. UHS CEO on healthcare deals

    Universal Health Services CEO Alan Miller discusses the business of healthcare and recent acquisitions.

  2. Hospira shares rise to new highs on Pfizer deal

    FBN’s Nicole Petallides on the highlights from the day in the markets.

  3. Midday Market Report: 2/5/15

    Jobless claims rise less than expected

  4. Hospira , Pfizer a good deal?

    Ariel Investments Vice Chairman Charles Bobrinskoy discusses the deal between Pfizer and Hospira and how he’s allocating capital.

  5. Pfizer eyes growth in biosimilar injectable market

    Canaccord Genuity U.S. Portfolio Strategist Tony Dwyer and Glenmede Director of Investment Strategy Jason Pride discuss money flow into the health-care sector.

  6. Pfizer buys Hospira

    FBN’s Liz MacDonald on Pfizer’s multi-billion dollar bet on Hospira .

  7. What drives the market?

    Canaccord Genuity U.S. Portfolio Strategist Tony Dwyer and Glenmede Director of Investment Strategy Jason Pride discuss their outlook for money flow into the U.S. and International economies.

‹ Prev12Next ›
Freebase CC-BY
Source: Hospira on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL